Physician profile
Lawrence M Eilender
NPI 1366445173
$73,356.33
in general payments reported to CMS, 2019-2025
93 companies · $7,542 in 2025
The $7,542 reported for 2025 was more than what 88% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $10K · 2021: $18K · 2022: $13K · 2023: $6,546 · 2024: $6,902 · 2025: $7,542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19K · Travel and Lodging: $1,102 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $788 · Consulting Fee: $300 · Education: $77.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18,723.74 |
| Travel and Lodging | $1,101.52 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $787.50 |
| Consulting Fee | $300.00 |
| Education | $77.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $19,262.98 | 2019-2025 | |
| Allergan, INC. | $9,458.45 | 2019-2022 | |
| Celgene Corporation | $5,091.03 | 2019-2025 | Zeposia |
| Novartis Pharmaceuticals Corporation | $3,052.76 | 2019-2025 | |
| Eisai INC. | $2,641.24 | 2019-2025 | |
| Emd Serono, INC. | $2,530.58 | 2019-2025 | Mavenclad, Mavenclad |
| Ucb, INC. | $2,285.83 | 2019-2025 | Briviact, Nayzilam, Rystiggo |
| Biogen, INC. | $1,997.35 | 2019-2025 | Tysabri, Vumerity, Avonex |
| Teva Pharmaceuticals USA, INC. | $1,966.06 | 2019-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Genzyme Corporation | $1,658.89 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $1,649.24 | 2021-2022 | |
| Livanova USA, INC. | $1,636.11 | 2021-2025 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Lilly USA, LLC | $1,149.96 | 2019-2025 | Emgality, Kisunla, Reyvow |
| Neurocrine Biosciences, INC. | $1,092.95 | 2019-2025 | Ingrezza, Ongentys |
| Pfizer INC. | $955.32 | 2021-2025 |
Show all 93 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $905.58 | 2019-2025 | Uplizna, Aimovig |
| Alnylam Pharmaceuticals INC. | $731.30 | 2019-2025 | Onpattro, Amvuttra |
| Genentech USA, INC. | $714.28 | 2019-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Alexion Pharmaceuticals, INC. | $683.28 | 2019-2025 | Ultomiris, Soliris |
| Tg Therapeutics, INC. | $646.66 | 2022-2025 | |
| Lundbeck LLC | $630.93 | 2019-2025 | Vyepti, Rexulti |
| Avanir Pharmaceuticals, INC. | $598.36 | 2019-2022 | |
| Argenx US, INC. | $597.92 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Acadia Pharmaceuticals INC | $549.19 | 2019-2025 | Nuplazid |
| Astrazeneca Pharmaceuticals Lp | $540.95 | 2021-2025 | Wainua, Andexxa, Evusheld |
| Neurelis, INC. | $529.85 | 2020-2025 | Valtoco |
| Sk Life Science, INC. | $437.17 | 2020-2025 | |
| Scilex Pharmaceuticals INC. | $426.47 | 2019-2024 | Ztlido |
| Kyowa Kirin, INC. | $387.97 | 2020-2024 | Nourianz |
| Amneal Pharmaceuticals LLC | $382.43 | 2019-2025 | Crexont, Rytary |
| Mdd US Operations, LLC | $377.99 | 2019-2021 | |
| Acorda Therapeutics, INC | $365.47 | 2019-2024 | Inbrija |
| Vanda Pharmaceuticals INC. | $353.67 | 2020-2025 | Ponvory |
| Takeda Pharmaceuticals U.S.A., INC. | $352.92 | 2022-2025 | Hyqvia, Gammagard |
| Catalyst Pharmaceuticals, INC. | $351.98 | 2020-2025 | Firdapse |
| E.R. Squibb & Sons, L.L.C. | $338.60 | 2020-2024 | Zeposia |
| Jazz Pharmaceuticals INC. | $332.98 | 2019-2025 | |
| Impel Pharmaceuticals INC. | $310.73 | 2022-2023 | Trudhesa |
| Horizon Therapeutics Plc | $310.17 | 2021-2023 | Uplizna |
| Csl Behring | $270.31 | 2019-2025 | Hizentra |
| Otsuka America Pharmaceutical, INC. | $265.64 | 2023-2025 | Rexulti, Nuedexta |
| Ani Pharmaceuticals, INC. | $255.99 | 2022-2025 | Purified Cortrophin Gel |
| Biohaven Pharmaceutical Holding Company Ltd. | $241.45 | 2022 | |
| Axsome Therapeutics, INC. | $224.34 | 2024-2025 | Symbravo, Sunosi |
| Biohaven Pharmaceuticals, INC. | $221.48 | 2021 | |
| Sunovion Pharmaceuticals INC. | $211.38 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $210.47 | 2023-2024 | Aptiom |
| Supernus Pharmaceuticals, INC. | $182.50 | 2019-2022 | |
| Corium, LLC | $170.81 | 2022-2023 | Adlarity |
| Adamas Pharmaceuticals, INC. | $169.74 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $144.92 | 2020-2022 | |
| Grifols USA, LLC | $141.73 | 2019-2023 | Gamunex-C |
| Nevro Corp. | $134.92 | 2024 | Senza |
| Sanofi-Aventis U.S. LLC | $134.70 | 2019-2021 | |
| Banner Life Sciences, LLC | $132.60 | 2021-2022 | |
| Upsher-Smith Laboratories LLC | $131.86 | 2020-2023 | |
| Innovation Technologies INC | $128.42 | 2022 | |
| Harmony Biosciences LLC | $119.78 | 2020-2025 | |
| Akcea Therapeutics, INC. | $112.07 | 2019-2021 | |
| Greenwich Biosciences, INC. | $110.02 | 2019-2020 | |
| Tanabe Pharma America, INC. | $108.07 | 2019-2025 | Radicava |
| Octapharma USA, INC. | $91.41 | 2023-2025 | Panzyga |
| Cycle Pharmaceuticals INC | $85.96 | 2024-2025 | Tascenso Odt, Bafiertam, Ormalvi |
| Validus Pharmaceuticals LLC | $77.50 | 2019-2023 | Equetro |
| Cala Health, INC. | $68.32 | 2022-2023 | Cala Trio, Cala Kiq |
| Assertio Therapeutics, INC. | $65.23 | 2019-2020 | |
| Idorsia Pharmaceuticals US INC | $63.36 | 2022-2023 | Quviviq |
| Mallinckrodt Enterprises LLC | $60.53 | 2019 | |
| Avion Pharmaceuticals | $58.05 | 2022 | |
| Promius Pharma LLC | $54.86 | 2019 | |
| Currax Pharmaceuticals LLC | $48.91 | 2020-2021 | |
| Hospira, INC. | $47.90 | 2024-2025 | |
| Aquestive Therapeutics, INC. | $46.15 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $42.75 | 2023-2025 | Keveyis |
| Aprecia Pharmaceuticals, LLC | $36.30 | 2019-2020 | |
| Ge Healthcare | $35.16 | 2019 | |
| Bausch Health US, LLC | $32.94 | 2019 | |
| Globus Medical, INC. | $31.74 | 2025 | Senza |
| Zyla Life Sciences, INC. | $27.96 | 2020 | |
| Azurity Pharmaceuticals, INC. | $27.10 | 2024 | Horizant |
| Averitas Pharma INC. | $26.49 | 2024 | Qutenza |
| Merz Pharmaceuticals, LLC | $25.19 | 2024 | Inbrija |
| Aucta Pharmaceuticals, INC. | $25.04 | 2025 | Motpoly Xr |
| Avadel Cns Pharmaceuticals, LLC | $24.09 | 2024 | Lumryz |
| Genentech, INC. | $22.01 | 2019 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $21.55 | 2024 | Rexulti |
| Sobi, INC | $18.13 | 2021 | |
| Abbott Laboratories | $17.90 | 2025 | Infinity |
| Owp Pharmaceuticals, INC. | $15.29 | 2023 | Subvenite, Lamotrigine |
| Neuronetics, INC. | $14.65 | 2025 | Neurostar Tms Therapy System |
| Alfasigma USA, INC. | $12.13 | 2022 | |
| Strongbridge US INC. | $11.80 | 2020 | |
| Biodelivery Sciences International, INC. | $11.13 | 2021 |
Drugs and devices associated with these payments
Vns Therapy $1,562Ubrelvy $1,265Kesimpta $1,182Qulipta $1,161Tysabri $857Ingrezza $665Mavenclad $642Nurtec Odt $642Zeposia $602Briumvi $595Briviact $567Zavzpret $557Botox $497Nayzilam $487Wainua $442Valtoco $390Nuplazid $385Rexulti $375Onpattro $374Austedo Xr $330Vumerity $307Ultomiris $296Vyepti $286Uplizna $281Epidiolex $263Vyvgart $253Ocrevus $252Vyvgart Hytrulo $248Nourianz $239Panzyga $233Ponvory $218Rystiggo $215Aptiom $210Ajovy $201Purified Cortrophin Gel $194Emgality $192Hyqvia $187Leqembi $184Duopa $182Kisunla $178Reyvow $177Senza $167Ongentys $158Ocrevus Zunovo $156Adlarity $155Avonex $153Symbravo $153Trudhesa $152Enspryng $151Amvuttra $128Crexont $110Vraylar $108Hizentra $105Inbrija $104Aubagio $101Amyvid $99.87Firdapse $91.86Comirnaty $89.59Paxlovid $89.59Wakix $89.47Octagam Immune Globulin (Human) $86.71Radicava $86.70Nuedexta $79.79Ztlido $77.43Gammagard $76.07Sunosi $71.64Tascenso Odt $70.30Austedo $68.71Fintepla $67.34Soliris $64.16Fycompa $62.25Vns Therapy Sentiva Model 1000 Generator $59.22Radicava Ors $54.89Cala Trio $52.71Rytary $52.18Skyclarys $51.29Spinraza $44.57Andexxa $44.08Keveyis $42.75Quviviq $42.58Bafiertam $41.84Nexviazyme $36.00Horizant $27.10Qutenza $26.49Equetro $25.53Motpoly Xr $25.04Gamunex-C $24.22Lumryz $24.09Elyxyb - Celecoxib $22.90Aimovig $18.92Infinity $17.90Evusheld $16.30Cala Kiq $16.21Ormalvi $15.66Lamotrigine $15.29Subvenite $15.29Zembrace Symtouch $14.91Neurostar Tms Therapy System $14.65
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Eilender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.